The objective of this study was to determine if there were health economic advantages related to treatment compared to no pharmacological treatment. (Source: Value in Health)
Comparison of Health Care Resource use and Costs in Patients with Opioid Prescription Drug Dependence (Opd) Treated with Buprenorphine/Naloxone and Patients without Pharmacological Treatment: Retrospective Analysis of us Public Insurance Claims
Previous post: Buprenorphine/naloxone pediatric ingestion: Exposure rates differ between film and tablet formulations
